Table 1.
Maternal | Fetal | |||
---|---|---|---|---|
|
|
|||
Control | Mg deficient | Control | Mg deficient | |
FA (mg per 100 mg liver) | ||||
| ||||
14:0 | 0.36 ± 0.22 | 0.74 ± 0.13** | 1.75 ± 0.21 | 1.55 ± 0.19 |
16:0 | 30.2 ± 0.86 | 30.8 ± 2.55 | 27.8 ± 1.00 | 26.3 ± 0.58* |
16:1 | 2.02 ± 0.34 | 3.63 ± 1.02** | 5.21 ± 0.30 | 4.74 ± 0.68 |
18:0 | 4.46 ± 0.48 | 4.8 ± 0.82 | 7.89 ± 0.87 | 8.75 ± 0.94 |
18:1n-7 | 2.70 ± 0.25 | 3.01 ± 0.59 | 3.90 ± 0.23 | 3.37 ± 0.38* |
18:1n-9 | 30.3 ± 2.54 | 34.7 ± 2.68** | 38.1 ± 1.60 | 32.8 ± 2.48** |
18:2n-6 | 24.2 ± 2.74 | 19.3 ± 4.96* | 13.8 ± 1.90 | 19.4 ± 2.62*** |
18:3n-6 | 0.97 ± 0.18 | 0.48 ± 0.58* | 0.36 ± 0.36 | 0.78 ± 0.35* |
18:3n-3 | 0.54 ± 0.37 | 0.37 ± 0.99* | 0.23 ± 0.34 | 0.87 ± 0.46* |
20:4n-6 | 2.80 ± 0.57 | 1.24 ± 0.44*** | 0.26 ± 0.27 | 0.71 ± 0.33* |
22:6n-3 | 1.41 ± 0.42 | 0.19 ± 0.33*** | 0.67 ± 0.05 | 0.93 ± 0.17* |
| ||||
Percentage of total | ||||
| ||||
MUFA | 37.0 ± 1.20 | 39.8 ± 3.06* | 47.0 ± 1.80 | 40.1 ± 3.56** |
SFA | 33.0 ± 2.70 | 40.0 ± 3.20** | 37.4 ± 1.80 | 37.1 ± 1.73 |
PUFA | 30.0 ± 2.96 | 20.2 ± 6.07** | 15.6 ± 2.67 | 22.8 ± 4.17** |
| ||||
Ratio | ||||
| ||||
PUFA:SFA | 0.86 ± 0.10 | 0.63 ± 0.23* | 0.33 ± 0.16 | 0.61 ± 0.24** |
n-3:n-6 FA | 0.07 ± 0.01 | 0.06 ± 0.01* | 0.06 ± 0.02 | 0.09 ± 0.01* |
| ||||
Activity | ||||
| ||||
Desaturation indexa | 1.00 ± 0.08 | 1.14 ± 0.09* | 1.26 ± 0.07 | 1.12 ± 0.1* |
ELOVL6b | 1.15 ± 0.09 | 1.29 ± 0.06* | 1.65 ± 0.04 | 1.58 ± 0.09 |
Values are means ± SD; n = 8–9 per group.
Total desaturation index = (16:1n-7 + 18:1n-7 + 18:1n-9)/(14:0 + 16:0 + 18:0).
ELOVL6 (elongase 6) activity index = (18:0 + 18:1n-9)/16:0.
P < 0.05,
P < 0.01,
P < 0.0001 versus control.